Ovarian cyst syndrome .. a recent study that revives the hope of treatment

The ovarian cysts affect the lives of many women as it causes the appearance of young people’s love and an increase in hair and a neck, and after years of research, it has not yet been achieved after a treatment that directly targets this syndrome, although a recent study gives hope to find a final solution for it. The study, conducted by a Chinese team and published in the prestigious magazine “Sains” in mid -June, confirmed that there are only limited possibilities for ovarian cysts. “The study provides a promising way to treat this syndrome that does not receive a relatively good attention in the media, even if it is a woman from every ten women, it causes symptoms that are often painful and exhausting, and the cystic syndrome of the ovaries occurs due to excessive production of male hormones, and the presence of more natural amounts. Patients with patients, it is very good with patients with patients, it is in many patients, it is in many patients, with many patients, it is in many patients, with many patients, it is in many patients, with many patients, it is in many patients, it is in many patients who are translated with patients. Infertility, even if they have permanently children, in addition to the possibility of diabetes. which directly limits the production of ovaries for male hormones, and to reduce these hormones. Researchers have used a common anti -malaria drug, Ancientinin, and they have noticed a common improvement in cases of about twenty patients. The medical circles have welcomed these results, although for the time being, to ensure whether artemisinin is already working against the Synroms of the ovaries, it is necessary to test it on a large number of other patients and compare the results with imaginary treatment. Although the results that the study has touched are provisional, this research was important because patients have not seen years of research, that is, tangible progress that can help them. In an interview with “Agence France Presse”, endocrinologist Elizabeth Steiner-Victorran, one of the most prominent experts in the world in this syndrome: “There are many things we do not know, but we cannot say that progress does not exist.” On the one hand, the physiological mechanisms of the syndrome became better known, and its diagnosis was improved to become more accurate, and eventually its identity on health became more accurate, and these effects became cardiovascular problems, and the effects of mental health that were neglected a few years ago. But there is still unclear, for example when the syndrome in the ovaries itself is rooted, or leads to an imbalance in the nervous system. Last year, international experts developed an extensive summary to review the knowledge of the ovarian syndrome, direct doctors on this topic, and fight the medical community to provide assertive answers to many of the syndrome. There is an agreement on the need to improve the lifestyle of patients, specifically those suffering from weight gain, but the study also indicates a lack of data to know what should be accurately recommended on diet and physical activity. Can the field of manufacturing medicine take the subject on his shoulder and give good financing? There are small small indicators, including the collection of donations, which were eventually arranged by an emerging business to create a solution to the infertility problem caused by the infection of ovarian syndrome. The group, called “My Health”, collected about twenty million euros, specifically from the French General Bank “BPI France”, to manufacture the “Ovaries Re -Balance” device that has not yet been proven. Will other businesses follow the example of “my health”? The general atmosphere is currently a favorable focus on women’s health, especially with the strong media attention that the uterine blanket is improvised. The financial analyst specializing in the production of medicine, Jamila Al -Burjouri, told Agence France Presse that “ovarian contact syndrome affects a relatively large number of population, and it is besides an attractive market in theory.” It is clear that the financing assigned to this field is less than other diseases, which have similar effects, such as romatic arthritis, “stress than the disordates associated with the metab oil. Cyst syndrome is a challenge for medical research.